Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Aytu Biopharma (AYTU) Leases (2019 - 2025)

Aytu Biopharma (AYTU) has disclosed Leases for 7 consecutive years, with $959000.0 as the latest value for Q4 2025.

  • Quarterly Leases fell 18.59% to $959000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $959000.0 through Dec 2025, down 18.59% year-over-year, with the annual reading at $1.1 million for FY2025, 27.99% up from the prior year.
  • Leases for Q4 2025 was $959000.0 at Aytu Biopharma, down from $1.0 million in the prior quarter.
  • The five-year high for Leases was $3.8 million in Q4 2021, with the low at $700000.0 in Q3 2023.
  • Average Leases over 5 years is $2.2 million, with a median of $2.1 million recorded in 2023.
  • The sharpest move saw Leases skyrocketed 1138.41% in 2021, then crashed 76.48% in 2023.
  • Over 5 years, Leases stood at $3.8 million in 2021, then tumbled by 30.43% to $2.7 million in 2022, then decreased by 20.26% to $2.1 million in 2023, then tumbled by 44.77% to $1.2 million in 2024, then fell by 18.59% to $959000.0 in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $959000.0, $1.0 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.